China's Best One-Stop Medical Equipment Provider
About

Cellgen is developing a bio-fluid based molecular diagnostic that will serve as a therapeutic guidance platform for cancer patients. The platform incorporates machine learning to deliver intelligent, quantitative and actionable results to oncologists in under 5 hours. Designed to detect all DNA and RNAs, Cellgen's platform features a proprietary on-chip enrichment and detection workflow perfectly suited to be installed as the premier Companion Diagnostic testing system within leading oncology clinics. Running on Cellgen's proprietary platform, each disposable assay will yield inclusion / exclusion data, while also leveraging proprietary machine learning algorithms to intelligently monitor and predict therapeutic response. This information will help inform patients, physicians, and others on how best to simplify and optimize life-saving clinical protocols.

Technologies
OutlookGoDaddy HostingAmazon AWSWordPress.orgGoogle Font APIApacheVimeoMobile Friendly
Keywords
medical equipment manufacturingmedical and diagnostic laboratoriespredictive analyticsimmuno-oncology companion diagnosticsbiotech startupcancer therapy responsenon-amplification detectionservicesbiotech innovationreal-time diagnosticsdisposable cartridgesample enrichmentmachine learning in diagnosticsautoimmune disease monitoringautoimmune and inflammation testsrna transcriptome analysisbiomarker signature analysisbiomarker signatureevaporating droplet techniqueimmuno-oncology diagnosticshealthcare technologymachine learning algorithmsgenomic testingdiagnostic technologybiomarker-based therapy guidancerna-based diagnosticspoint-of-care molecular testingrna transcriptome profilingmolecular diagnosticspersonalized medicine
Company Information
  • Employees1
  • Founded2012
  • Annual Revenue$6655000
Location

7545 Irvine Center Drive, Irvine, California, United States, 92618

Related Companies
Companies in the same industry